Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Alnylam Pharmaceuticals, Inc. (ALNY)

« Back to company index

ALNY Chatter Timeline

Stock Ticker for ALNY

Most Active Tweeters for ALNY

UserTweets
@FlashAlert_me 7
@Gambiste1 5
@RNAiAnalyst 4
@ConsumerFeed 2
@WKRBNews 1

Recent Tweets for ALNY

42Stocks @42Stocks
#Alnylam Pharmaceuticals up 1.8% = $138.8 million gain. $ALNY has made notable gains in 5 of the last 14 trading se… https://t.co/iOFrIH8C86
July 15th 2019, 6:07pm
RNAiAnalyst @RNAiAnalyst
$ALNY's competing Lumasiran already head BTD.
July 15th 2019, 7:07am
RNAiAnalyst @RNAiAnalyst
$ALNY rationalizes that liver enzyme elevations only in patients w/ anti-HCV antibodies. 2 questions: 1) how many… https://t.co/XsRZh8e8Y6
July 15th 2019, 5:07am
battagliame30 @battagliame30
@RNAiAnalyst You talking older $ALNY RNAi-triggers possibly being more probed to miRNA homology?
July 13th 2019, 6:07pm
MogulAzam @MogulAzam
RT @RNAiAnalyst: Fitusiran another one of those RNAi triggers not optimized for targeting specificity. New generation different. $ALNY http…
July 13th 2019, 3:07pm
CentralChartsEN @CentralChartsEN
$ALNY #ALNYLAMPHARMACEUTICALS - Daily: In a bearish trend, the price of ALNYLAM PHARMACEUTICALS INC. tries to infla… https://t.co/2lwXSziz8d
July 12th 2019, 8:07am
Londinia_IA @Londinia_IA
$ALNY #ALNYLAMPHARMACEUTICALS - Daily: In a bearish trend, the price of ALNYLAM PHARMACEUTICALS INC. tries to infla… https://t.co/OzjrRqtvtQ
July 12th 2019, 8:07am
CarlyHFierce @CarlyHFierce
Alnylam recruits former Shire exec to replace departing CFO Soni: https://t.co/FLnBzeSFEm $ALNY #pharma
July 12th 2019, 7:07am
marketexclusive @marketexclusive
$ALNY Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Files An 8-K Departure of Directors or Certain Officers; Electio… https://t.co/UoT8PbPZxN
July 11th 2019, 5:07pm
fintel_io @fintel_io
$ALNY / Alnylam Pharmaceuticals files form 8-K https://t.co/2VCNl4PxYC - Regulation FD Disclosure, Departure of Dir… https://t.co/lluPA6xBcS
July 11th 2019, 4:07pm
confcalltran @confcalltran
Alnylam Pharmaceuticals Announces Transition Of Chief Financial Officer https://t.co/UlPt8aTGLH $ALNY
July 11th 2019, 4:07pm
filingsdb @filingsdb
New Form 8-K filed by ALNYLAM PHARMACEUTICALS, INC. $ALNY - https://t.co/jSljjpKeZO
July 11th 2019, 4:07pm
RNAiAnalyst @RNAiAnalyst
$ALNY does CFO 'transition' signal cash burn to decrease? https://t.co/kxlXVdXxgf
July 11th 2019, 12:07pm
robstanislaro @robstanislaro
RT @JohnCendpts: Alnylam’s Maraganore switches ‘perhaps the best CFO in mid-cap biotech’ with Shire vet Jeff Poulton $ALNY https://t.co/Ud0…
July 11th 2019, 11:07am
JohnCendpts @JohnCendpts
Alnylam’s Maraganore switches ‘perhaps the best CFO in mid-cap biotech’ with Shire vet Jeff Poulton $ALNY https://t.co/Ud0VURxmgu
July 11th 2019, 10:07am
AndrewE_Dunn @AndrewE_Dunn
Inbox: $ALNY CFO Manmeet Soni resigning "to pursue other interests." Will continue at Alnylam through Aug. 12, whil… https://t.co/1m0yEc8Jd5
July 11th 2019, 8:07am
ProVesting @ProVesting
$ALNY: Alnylam Pharmaceuticals Announces Transition of Chief Financial …: https://t.co/SeIgY5PXwA
July 11th 2019, 8:07am
Gambiste1 @Gambiste1
RT @trade4me_net: $ALNY Growth Stock, V & W Shape, Breakout Mode, Volume Accumulation, Institutional Buying $ 198.6 M, Institutional Owners…
July 11th 2019, 7:07am
trade4me_net @trade4me_net
$ALNY Growth Stock, V & W Shape, Breakout Mode, Volume Accumulation, Institutional Buying $ 198.6 M, Institutional… https://t.co/LRV3uJN1ky
July 10th 2019, 11:07pm
AmericanBanking @AmericanBanking
Alnylam Pharmaceuticals, Inc. $ALNY Receives Consensus Recommendation of “Buy” from Analysts https://t.co/KT3qlNPpLc #stocks
July 9th 2019, 2:07pm
WKRBNews @WKRBNews
Brokerages Expect Alnylam Pharmaceuticals, Inc. $ALNY Will Announce Quarterly Sales of $47.29 Million https://t.co/DzulJa50gu #markets
July 8th 2019, 9:07pm
ConsumerFeed @ConsumerFeed
Brokerages Expect Alnylam Pharmaceuticals, Inc. $ALNY Will Announce Quarterly Sales of $47.29 Million https://t.co/Pt5biwIxgW
July 8th 2019, 9:07pm
Gambiste1 @Gambiste1
RT @AlecJones10: Definitely not a clean safety profile for fitu $alny https://t.co/ACS2WIsZs6
July 7th 2019, 11:07am
Gambiste1 @Gambiste1
RT @MSS1992BIO: $alny this suggests to me that continued dosing of escgalnac is definitely not safe. $mdco will not see these side effects…
July 7th 2019, 11:07am
MSS1992BIO @MSS1992BIO
$alny this suggests to me that continued dosing of escgalnac is definitely not safe. $mdco will not see these side… https://t.co/cGbgIdaboK
July 7th 2019, 10:07am
ConsumerFeed @ConsumerFeed
Brokerages Expect Alnylam Pharmaceuticals, Inc. $ALNY to Announce -$1.81 Earnings Per Share https://t.co/Od5qBOomcy
July 6th 2019, 10:07pm
IRAMarketReport @IRAMarketReport
Zacks: Analysts Anticipate Alnylam Pharmaceuticals, Inc. $ALNY Will Post Quarterly Sales of $47.29 Million https://t.co/TW1GZglI4U #markets
July 6th 2019, 10:07pm
chaffeybreeze @chaffeybreeze
Zacks: Analysts Anticipate Alnylam Pharmaceuticals, Inc. $ALNY Will Post Quarterly Sales of $47.29 Million https://t.co/Hjn7WQygAS #stocks
July 6th 2019, 10:07pm
AlecJones10 @AlecJones10
Definitely not a clean safety profile for fitu $alny https://t.co/ACS2WIsZs6
July 6th 2019, 9:07pm
FlashAlert_me @FlashAlert_me
$ALNY filed form CT ORDER on July 05, 10:07:37 https://t.co/D3WI1uFL2k
July 5th 2019, 10:07am
registrarjourn @registrarjourn
Alnylam Pharmaceuticals, Inc. $ALNY Expected to Announce Earnings of -$1.81 Per Share https://t.co/f3TZzOlCEc
July 4th 2019, 2:07pm
EnterpriseLeade @EnterpriseLeade
Alnylam Pharmaceuticals, Inc. $ALNY Expected to Announce Earnings of -$1.81 Per Share https://t.co/0pVL72EeL7
July 4th 2019, 2:07pm
dispatchtribune @dispatchtribune
Brokerages Expect Alnylam Pharmaceuticals, Inc. $ALNY to Announce -$1.81 EPS https://t.co/cfBz4AUZj6
July 4th 2019, 2:07pm
OlympiaReport @OlympiaReport
Alnylam Pharmaceuticals, Inc. $ALNY Expected to Announce Earnings of -$1.81 Per Share https://t.co/rcZsQ4OjeH
July 4th 2019, 2:07pm
IonisDisrupts @IonisDisrupts
@RNAiAnalyst #Onpattro is so much better that $Alny withheld 2nd year data of ole. $ions didn’t.
July 4th 2019, 11:07am
Gambiste1 @Gambiste1
RT @SwingTradeIdeas: $ALNY - Alnylam (ALNY) Upgraded to Strong Buy: What Does It Mean for the Stock? https://t.co/Mr1R677rVw
July 4th 2019, 10:07am
SwingTradeIdeas @SwingTradeIdeas
$ALNY - Alnylam (ALNY) Upgraded to Strong Buy: What Does It Mean for the Stock? https://t.co/Mr1R677rVw
July 4th 2019, 10:07am
OTSociety @OTSociety
Investigational #RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of #Myasthenia Gravis $ALNY… https://t.co/4JrlkLgCtK
July 3rd 2019, 11:07am
Gambiste1 @Gambiste1
RT @RNAiAnalyst: $abus royalty to $ALNY's Patisiran worth more than I had thought. Sold to a pension plan in Ontario no less! https://t.co…
July 3rd 2019, 3:07am
RNAiAnalyst @RNAiAnalyst
$abus royalty to $ALNY's Patisiran worth more than I had thought. Sold to a pension plan in Ontario no less! https://t.co/LQSdppa81h
July 2nd 2019, 4:07pm
FlashAlert_me @FlashAlert_me
$ALNY filed SEC form 4: Director BONNEY MICHAEL W: https://t.co/Q8CeGCPjdo
July 2nd 2019, 4:07pm
FlashAlert_me @FlashAlert_me
$ALNY filed SEC form 4: Director SCHULMAN AMY W: https://t.co/GLyiaNKor2
July 2nd 2019, 4:07pm
FlashAlert_me @FlashAlert_me
$ALNY filed SEC form 4: Director SHARP PHILIP A: https://t.co/aSgbOV3wHw
July 2nd 2019, 4:07pm
FlashAlert_me @FlashAlert_me
$ALNY filed SEC form 4: Director SCHIMMEL PAUL: https://t.co/jIySNfqTr3
July 2nd 2019, 4:07pm
InsiderAlertsIA @InsiderAlertsIA
$ALNY: New Insider Filing on Director DENNIS A AUSIELLO: https://t.co/gPBROHB3FP
July 2nd 2019, 4:07pm
FlashAlert_me @FlashAlert_me
$ALNY filed SEC form 4: Director Reitan Colleen F: https://t.co/4uaA9tMNBg
July 2nd 2019, 4:07pm
FlashAlert_me @FlashAlert_me
$ALNY filed SEC form 4: Director PAUL STEVEN M: https://t.co/dcdpgkC60r
July 2nd 2019, 4:07pm
bthefirsttoknow @bthefirsttoknow
$ABUS $ALNY Arbutus Sells Part of its ONPATTRO™ (patisiran) Royalty Interest to OMERS https://t.co/9HXENLtzTY
July 2nd 2019, 4:07pm
SwingTradeBot @SwingTradeBot
50 DMA Resistance today: $CONE $ALNY ... https://t.co/mnYaiRq1wk
July 2nd 2019, 3:07pm
portefeuillefun @portefeuillefun
Sold 200 $ALNY at $73.36, now 300 #vssporte shares.
July 2nd 2019, 12:07pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.